If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript-enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
Issue 3 July 2011
Drug Delivery
Better Medicine
From needle-free to nanotechnology, new drug delivery
systems are set to revolutionise medical treatment
Pharma
Technology Focus
IN THIS ISSUE
Goodbye to daily injections?
Spotlight on the oral drugs market
Risk vs revenue: combination drugs
Contents
Issue #3 July 2011
A New Era for Drug Delivery
Drug delivery technologies are coming of age
and attracting major investment
Special Delivery
We examine the driving factors for future
growth in the global drug delivery market
Money Where the Mouth Is
The oral drugs sector is expected to continue its
next five years
ctions?
systems could open
ering medication
emerging as a key
petitive market
me the challenges of
to market
Drug Delivery
Ph
Issue 3 July 2011 Drug Delivery
Contents Issue #3 July 2011 A New E
ULTRA-TURRAX® Tube Drive control World‘s first:
Industry News Navigation: Select a news catego
Companies and academic institutions worldwide are
Drug delivery technologies are coming of age and
MUCH INVESTMENT WILL CONTINUE TO BE DIRECTED TOWA
An Unparalleled Global Face-2-Face
Special Delivery As the pharmaceutical industry
We have a challenging and inspiring mission: To i
Accounting for more than half of the dru
The drug delivery market is gradually becoming an
A focus on paediatric and geriatric markets has f
Encap Drug Delivery Global Experts in Oral Drug D
GOODBYE TO DAILY INJECTIONS? Research suggests th
“ THE USE OF DRUG DELIVERY SYSTEMS IS OFTEN A
The Bio-Images Group provides in
MUTUALLY BENEFICIAL LIKE MOST BUSINESSES AROUND T
Faced with a host of market challenges, such as d
Drug Delivery Devices
i RiskyBus Developing combination drugs and bring
“ Many biologic products are high-
Pharma Technology Focus Editorial Duncan West
2nd Annual KEY REASONS TO ATTEND: Explo